5V4M
Structure of HLA-DR15 with bound alpha3(135-145) peptide
Summary for 5V4M
Entry DOI | 10.2210/pdb5v4m/pdb |
Descriptor | HLA-DRA1, alpha3(135-145)-HLA-DRB1*15:01, alpha-L-fucopyranose-(1-3)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total) |
Functional Keywords | hla-dr, immune complex, antigen presenation, immune system |
Biological source | Homo sapiens (Human) More |
Cellular location | Cell membrane; Single-pass type I membrane protein: P01903 P01911 |
Total number of polymer chains | 8 |
Total formula weight | 189016.73 |
Authors | Petersen, J.,Rossjohn, J. (deposition date: 2017-03-10, release date: 2017-05-03, Last modification date: 2024-10-09) |
Primary citation | Ooi, J.D.,Petersen, J.,Tan, Y.H.,Huynh, M.,Willett, Z.J.,Ramarathinam, S.H.,Eggenhuizen, P.J.,Loh, K.L.,Watson, K.A.,Gan, P.Y.,Alikhan, M.A.,Dudek, N.L.,Handel, A.,Hudson, B.G.,Fugger, L.,Power, D.A.,Holt, S.G.,Coates, P.T.,Gregersen, J.W.,Purcell, A.W.,Holdsworth, S.R.,La Gruta, N.L.,Reid, H.H.,Rossjohn, J.,Kitching, A.R. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells. Nature, 545:243-247, 2017 Cited by PubMed Abstract: Susceptibility and protection against human autoimmune diseases, including type I diabetes, multiple sclerosis, and Goodpasture disease, is associated with particular human leukocyte antigen (HLA) alleles. However, the mechanisms underpinning such HLA-mediated effects on self-tolerance remain unclear. Here we investigate the molecular mechanism of Goodpasture disease, an HLA-linked autoimmune renal disorder characterized by an immunodominant CD4 T-cell self-epitope derived from the α3 chain of type IV collagen (α3). While HLA-DR15 confers a markedly increased disease risk, the protective HLA-DR1 allele is dominantly protective in trans with HLA-DR15 (ref. 2). We show that autoreactive α3-specific T cells expand in patients with Goodpasture disease and, in α3-immunized HLA-DR15 transgenic mice, α3-specific T cells infiltrate the kidney and mice develop Goodpasture disease. HLA-DR15 and HLA-DR1 exhibit distinct peptide repertoires and binding preferences and present the α3 epitope in different binding registers. HLA-DR15-α3 tetramer T cells in HLA-DR15 transgenic mice exhibit a conventional T-cell phenotype (T) that secretes pro-inflammatory cytokines. In contrast, HLA-DR1-α3 tetramer T cells in HLA-DR1 and HLA-DR15/DR1 transgenic mice are predominantly CD4Foxp3 regulatory T cells (T cells) expressing tolerogenic cytokines. HLA-DR1-induced T cells confer resistance to disease in HLA-DR15/DR1 transgenic mice. HLA-DR15 and HLA-DR1 healthy human donors display altered α3-specific T-cell antigen receptor usage, HLA-DR15-α3 tetramer Foxp3 T and HLA-DR1-α3 tetramer Foxp3CD25CD127 T dominant phenotypes. Moreover, patients with Goodpasture disease display a clonally expanded α3-specific CD4 T-cell repertoire. Accordingly, we provide a mechanistic basis for the dominantly protective effect of HLA in autoimmune disease, whereby HLA polymorphism shapes the relative abundance of self-epitope specific T cells that leads to protection or causation of autoimmunity. PubMed: 28467828DOI: 10.1038/nature22329 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report
